Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Phase II trial of elesclomol (formerly STA-4783) and paclitaxel in stage IV metastatic melanoma (MM): Subgroup analysis by prior chemotherapy

Gonzalez R, Lawson DH, Weber RW, Hutchins L, Anderson CM, Williams KN, Kong S, Jacobson E, O'Day SJ. Phase II trial of elesclomol (formerly STA-4783) and paclitaxel in stage IV metastatic melanoma (MM): Subgroup analysis by prior chemotherapy. J Clin Oncol 26 (May 20 suppl). 2008.